Navigation Links
Gentiva Reports Strong Second Quarter led by Home Health Segment
Date:7/31/2008

nses, depreciation, amortization, and interest expense (net), but include revenues and all other costs directly attributable to the specific segment.

2) EBITDA, a non-GAAP financial measure, is defined as income before interest expense (net of interest income), income taxes, depreciation and amortization. Management uses EBITDA to evaluate overall performance and compare current operating results with other companies in the healthcare industry. EBITDA should not be considered in isolation or as a substitute for net income, operating income or cash flow statement data determined in accordance with accounting principles generally accepted in the United States. Because EBITDA is not a measure of financial performance under accounting principles generally accepted in the United States and is susceptible to varying calculations, it may not be comparable to similarly titled measures in other companies.

3) Operating contribution and EBITDA for the second quarter and first half of 2008 included restructuring and integration costs of $0.4 million and $0.7 million, respectively. For the second quarter and first half of 2007, operating contribution and EBITDA included restructuring and integration costs of $0.6 million and $1.6 million, respectively. The restructuring and integration costs were reflected as follows for segment reporting (dollars in millions):

2nd Quarter Six Months

2008 2007 2008 2007

Home Health $0.1 $0.1 $0.2 $0.4

Other Related Services - 0.1 - 0.1

Corporate 0.3 0.4 0.5 1.1

Total $0.4 $0.6 $0.7 $1.6

4) Commercial insurance and other revenues included revenues from Medicare Advantage business paid on an episodic basis of $13.4 million and $
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. United Therapeutics Reports Second Quarter 2008 Financial Results
2. The Quigley Corporation Reports Second Quarter 2008 Results: Continues Investment in Pharmaceutical R&D Future
3. Neurocrine Biosciences Reports Second Quarter 2008 Results
4. Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights
5. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
6. Idenix Pharmaceuticals Reports Second Quarter and Six Month Financial Results
7. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009
8. Cepheid Reports Second Quarter Revenue of $42.1 Million
9. Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009
10. Lilly Reports Solid Second-Quarter Results
11. Sangamo BioSciences Reports Second Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , , , , , , , ... AUDIO: , A team of scientists from Was... Arizona, Cold Spring Harbor Laboratory and Iowa S... corn. The... , , Click here for ... , , , , , , , ...
(Date:11/20/2009)...atin American countries have an opportunity to tak...earchers from the University of Valencia (UV), wor...udied the productive fabric of the Spanish biotech...food and plant sectors have more clout than those ...s applied to food and plants has been overlooked b...
(Date:11/20/2009)...N DIEGO, Nov. 20 Veridiam (www.ver...e mid-size company category at the 2009 Workplace ... San Diego Society for Human Resources Management ...ources practices. ,, Veridiam was one of nine w...ated companies, honored at the recent awards cerem...
(Date:11/20/2009)...EATTLE, Nov. 20 Dendreon... the U.S. Food and Drug Administration (FDA) provi...nded Biologics License Application (BLA) for PROVE...The FDA has assigned a Prescription Drug User Fee ...will respond to Dendreon,s amended BLA. Dendreon ...
Breaking Biology Technology:Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4Spanish biotechnology should focus on food and plant sectors to be more competitive 2Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3
...looking for an ambitious mission statement, consid...l Finance Adequacy Initiative: "We will not simply...ars, but propose a complete new reuse of all dolla...ol) system, and then any additional dollars if tha...om Still is a member of the initiative] , ,In oth...
... Wis. The Eau Claire Area Economic Development ...rting up again, offering cash awards of up to $10,...nty. , ,For interested entrepreneurs, the EDC is h...en entrants in the Creating Your Own Business Con...ications. , ,Businesses judged to have the best pl...
...now you,ve had a chance to absorb all the news fro...ators, stage presentations here -- click on DEMO... a company). , ,One question that always swirls ar...t want to know what wasn,t at DEMO. The premise of...at hundreds of products and companies and bring on...
Other Biology Technology:Measuring what works and what doesn't in the prototypical school 2Measuring what works and what doesn't in the prototypical school 3Why companies don't get invited to the DEMO conference 2Why companies don't get invited to the DEMO conference 3
(Date:11/21/2009)...ed, Germany, November 20,2009 / b3c newswire / -...tion of a financing round, gaining two new investo...he same time KINAXO reports that Jrgen Schumacher ...dvisory board. , KINAXO shareholders Axel Ullric... companys institutional investors Mountain Partner...
(Date:11/20/2009)...researchers are at work on many scientific and tec...ion has recently provided support that totals near...lowing investigators under the American Recovery a...s have been awarded grants for investigation of so...essor of physics, will enhance the capabilities of...
(Date:11/20/2009)...search report published in the November 2009 issue...rg ), scientists show how a family of genes (1-ami...s) are responsible for production of ethylene. Thi...nd this information lays the foundation for future...se resistant, able to survive and thrive in diffic...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2It's a gas: New discovery may lead to heartier, high-yielding plants 2Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 57298 1Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 57298 2Cleveland Lawyers Recognized by Peers on The Best Lawyers in America List 57298 3Top 15 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac 14069 1Top 15 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac 14069 2ISSA Recognized as Military Friendly School 57294 1ISSA Recognized as Military Friendly School 57294 2
...N, Va., Nov. 18 Stanley, Inc.,(NYSE: SXE ), a l...ional,services to the U.S. federal government, tod...ence Applications International Corporation (NYSE:...task order valued at up to $37.9 million, if,all t...the team will continue,to provide in-service engin...
...BRUNSWICK, N.J. Families gathering around the Tha... side dish that,s been given some "upscale" breedi...he age-old staple will look or taste no different ...elping growers increase production and improve fru...elping them meet the increasing year-round demand ...
...ork, NY, November 18, 2008 -- Researchers at the U...ed that two common cancer drugs have been used to ...F-funded study, published in The Proceedings of t...ey Bluestone, Ph.D., director of the Diabetes Cent...ity. , "The findings suggest that kinase inhibito...
Other Biology News:Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 2Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army 3Favorite Thanksgiving dish gets 'upscale' breeding 2
ChemiArray Mouse Lysate Atherosclerosis Antibody Array I, 20 cytokines per membrane from CHEMICON
High-Binding EIA 96 Well Plates from Cayman Chemical
Rabbit Complement from Equitech-Bio
Zymoclean Gel DNA Recovery Kit from Zymo Research
Biology Products: